ACS, Breast Cancer Facts & Figures 2019–2020 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf. 2021, American Cancer Society (ACS).

Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol. 2004;22(10):1849–56. https://doi.org/10.1200/Jco.2004.04.173.

Article  PubMed  Google Scholar 

Michael YL, Kawachi I, Berkman LF, Holmes MD, Colditz GA. The persistent impact of breast carcinoma on functional health status: prospective evidence from the Nurses’ Health Study. Cancer. 2000;89(11):2176–86. https://doi.org/10.1002/1097-0142(20001201)89:11%3c2176::aid-cncr5%3e3.0.co;2-6.

Article  CAS  PubMed  Google Scholar 

Karlsen RV, Frederiksen K, Larsen MB, von Heymann-Horan AB, Appel CW, Christensen J, et al. The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer. Acta Oncol. 2016;55(6):720–7. https://doi.org/10.3109/0284186X.2015.1127415.

Article  PubMed  Google Scholar 

Michael YL, Wu C, Pan K, Seguin-Fowler RA, Garcia DO, Zaslavsky O, et al. Postmenopausal breast cancer and physical function change: a difference-in-differences analysis. J Am Geriatr Soc. 2020;68(5):1029–36. https://doi.org/10.1111/jgs.16323.

Article  PubMed  Google Scholar 

CDC. Cognitive impairement: a call for action, now! https://www.cdc.gov/aging/pdf/cognitive_impairment/cogimp_poilicy_final.pdf. 2011 [cited 2022 April 15].

Orszaghova Z, Mego M, Chovanec M. Long-term cognitive dysfunction in cancer survivors. Front Mol Biosci. 2021;8:770413. https://doi.org/10.3389/fmolb.2021.770413.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39(3):297–304. https://doi.org/10.1016/j.ctrv.2012.11.001.

Article  CAS  PubMed  Google Scholar 

Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol. 2012;30(29):3578–87. https://doi.org/10.1200/JCO.2011.39.5640.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925–40. https://doi.org/10.1093/annonc/mdz410.

Article  CAS  PubMed  Google Scholar 

Lee PE, Tierney MC, Wu W, Pritchard KI, Rochon PA. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Res Treat. 2016;158(3):407–20. https://doi.org/10.1007/s10549-016-3906-9.

Article  CAS  PubMed  Google Scholar 

Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, et al. Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Med. 2014;3(3):702–9. https://doi.org/10.1002/cam4.174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dijkshoorn ABC, van Stralen HE, Sloots M, Schagen SB, Visser-Meily JMA, Schepers VPM. Prevalence of cognitive impairment and change in patients with breast cancer: a systematic review of longitudinal studies. Psychooncology. 2021;30(5):635–48. https://doi.org/10.1002/pon.5623.

Article  PubMed  PubMed Central  Google Scholar 

Billiet T, Emsell L, Vandenbulcke M, Peeters R, Christiaens D, Leemans A, et al. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging Behav. 2018;12(1):64–77. https://doi.org/10.1007/s11682-016-9665-8.

Article  PubMed  Google Scholar 

Ahles TA, Saykin AJ, McDonald BC, Li YL, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010;28(29):4434–40. https://doi.org/10.1200/Jco.2009.27.0827.

Article  PubMed  PubMed Central  Google Scholar 

Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348–56. https://doi.org/10.1002/cncr.25098.

Article  PubMed  Google Scholar 

Koppelmans V, Breteler MMB, Boogerd W, Seynaeve C, Gundy C, Schagen SB. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012;30(10):1080–6. https://doi.org/10.1200/Jco.2011.37.0189.

Article  PubMed  Google Scholar 

Sardella A, Catalano A, Lenzo V, Bellone F, Corica F, Quattropani MC, et al. Association between cognitive reserve dimensions and frailty among older adults: a structured narrative review. Geriatr Gerontol Int. 2020;20(11):1005–23. https://doi.org/10.1111/ggi.14040.

Article  PubMed  Google Scholar 

Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, et al. Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 2016;122(22):3555–63. https://doi.org/10.1002/cncr.30208.

Article  PubMed  Google Scholar 

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp. 2011;32(8):1206–19. https://doi.org/10.1002/hbm.21102.

Article  PubMed  Google Scholar 

Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat. 2007;103(3):303–11. https://doi.org/10.1007/s10549-006-9380-z.

Article  CAS  PubMed  Google Scholar 

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp. 2012;33(12):2971–83. https://doi.org/10.1002/hbm.21422.

Article  PubMed  Google Scholar 

Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267–75. https://doi.org/10.1007/s11910-012-0264-9.

Article  CAS  PubMed  Google Scholar 

Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990;263(5):665–8.

Article  CAS  PubMed  Google Scholar 

Vogt MT, Cauley JA, Scott JC, Kuller LH, Browner WS. Smoking and mortality among older women - the study of osteoporotic fractures. Arch Intern Med. 1996;156(6):630–6. https://doi.org/10.1001/archinte.156.6.630.

Article  CAS  PubMed  Google Scholar 

Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA. 1996;276(17):1404–8.

Article  CAS  PubMed  Google Scholar 

Grandits G and Neuhaus J. Using SAS® to perform individual matching in design of case-control studies https://support.sas.com/resources/papers/proceedings10/061-2010.pdf. in SAS Global Forum. 2010. Accessed 1 March 2022

Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40(7):812. https://doi.org/10.1001/archpsyc.1983.01790060110016.

Article  CAS  PubMed  Google Scholar 

Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000;22(4):518–28. https://doi.org/10.1076/1380-3395(200008)22:4;1-0;Ft518.

Article  CAS  PubMed  Google Scholar 

Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19(5):393–4. https://doi.org/10.1037/h0044509.

Article  CAS  PubMed  Google Scholar 

Blackwell T, Yaffe K, Ancoli-Israel S, Scheider JL, Cauley JA, Hillier TA, et al. Poor sleep is associated with impaired cognitive function in older women: the Study of Osteoporotic Fractures. Journals of Gerontology Series a-Biological Sciences and Medical Sciences. 2006;61(4):405–10. https://doi.org/10.1093/gerona/61.4.405.

Article  PubMed  Google Scholar 

Warton EM. Time after time: difference-in-differences and interrupted time series models in SAS. in SAS Global Forum 2020. 2020. https://www.sas.com/content/dam/SAS/support/en/sas-global-forum-proceedings/2020/4674-2020.pdf.

Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2018;168(2):299–310. https://doi.org/10.1007/s10549-017-4627-4.

Article  CAS  PubMed  Google Scholar 

Anstey KJ, Sargent-Cox K, Cherbuin N, Sachdev PS. Self-reported history of chemotherapy and cognitive decline in adults aged 60 and older: the PATH through life project. J Gerontol Ser a-Biol Sci Med Sci. 2015;70(6):729–35. https://doi.org/10.1093/gerona/glt195.

Article  CAS  Google Scholar 

Lange M, Heutte N, Rigal O, Noal S, Kurtz JE, Levy C, et al. Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist. 2016;21(11):1337–48. https://doi.org/10.1634/theoncologist.2016-0014.

Article  CAS  PubMed  PubMed Central  Google Scholar